Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Operating Expenses | 928 | 958 | 1,553 | 1,292 | 1,594 |
| Operating Income | -928 | -958 | -1,553 | -1,292 | -1,594 |
| Interest Expense | 11 | 5 | 1 | 3 | 1 |
| Other Income | -69 | 13 | 10 | -80 | 259 |
| Pre-tax Income | -1,008 | -950 | -1,544 | -1,375 | -1,336 |
| Net Income Continuous | -1,008 | -950 | -1,544 | -1,375 | -1,336 |
| Net Income | $-1,008 | $-950 | $-1,544 | $-1,375 | $-1,336 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.03 | -0.03 | -0.15 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.03 | -0.03 | -0.15 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.03 | -0.03 | -0.15 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.03 | -0.03 | -0.15 |
| EBITDA(a) | $-995 | $-944 | $-1,540 | $-1,370 | $-1,331 |